<DOC>
	<DOCNO>NCT01638572</DOCNO>
	<brief_summary>Well-regulated glycosylation essential normal development nervous system . Altered expression glycosyltransferases result dysregulated glycosylation neuroblastic cell might lead development NB . The β1,4-N-acetylgalactosaminyltransferase III ( B4GALNT3 ) exhibit GalNAc transferase activity form GalNAcβ1,4GlcNAc ( LacdiNAc LDN ) structure . The Drosophila B4GALNTA , homolog human B4GALNT3 , suggest regulate neuronal development . By immunohistochemical study , demonstrate expression B4GALNT3 correlate well histological grade differentiation NB tumor sample . Since well differentiate tumor usually carry good prognosis , thus speculate expression B4GALNT3 tumor tissue favorable prognostic factor NB . To explore role B4GALNT3 prognosis NB , propose follow project two specific aim : Aim Ⅰ : Establishing significance B4GALNT3 prognosis NB : We plan collect 90 NB tumor sample , evaluate RNA protein expression level Q-PCR , Western blot , immunohistochemistry tumor sample . The result compare clinicopathological biological factor NB . Also expression level B4GALNT3 tumor tissue correlate patient ' outcome clarify whether B4GALNT3 could prognosis marker NB . Aim II : Clarifying effect B4GALNT3 NB cell behavior vitro vivo . For strengthen prognostic role B4GALNT3 NB , NB cell phenotype behavior change overexpression knock-down B4GALNT3 evaluate vitro assay well nude mouse xenograft model . In summary , project establish role B4GALNT3 expression NB , may subclassify NB patient , give NB patient appropriate therapy improve patient ' outcome . Furthermore , B4GALNT3 could potentially serve therapeutic target future .</brief_summary>
	<brief_title>Exploring Possibility Use Glycosyltransferase Prognosis Marker Neuroblastoma</brief_title>
	<detailed_description />
	<mesh_term>Neuroblastoma</mesh_term>
	<criteria>Neuroblastoma patient complete followup sufficient sample study Neuroblastoma patient without complete followup sufficient sample study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Neuroblastoma</keyword>
	<keyword>B4GALNT3</keyword>
	<keyword>Prognosis</keyword>
</DOC>